TITLE

Improved Obesity Reduction and Co-morbidity Resolution in Patients Treated with 40-French Bougie Versus 50-French Bougie Four Years after Laparoscopic Sleeve Gastrectomy. Analysis of 294 Patients

AUTHOR(S)
Atkins, Emily; Preen, David; Jarman, Catherine; Cohen, Leon
PUB. DATE
January 2012
SOURCE
Obesity Surgery;Jan2012, Vol. 22 Issue 1, p97
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: We compared percent excess body mass index loss (%EBMIL) and resolution of dyslipidaemia, hypertension, and type 2 diabetes mellitus in the 4 years following laparoscopic sleeve gastrectomy (LSG) between patients calibrated with a 40-French (40F) or a 50-French (50F) bougie. Methods: We conducted a longitudinal retrospective descriptive study of routinely collected pre- and post-surgical data from 294 patients who underwent LSG at a single surgical centre (50F- n = 106, 40F- n = 185). Obesity measurements were taken prior to surgery and at regular intervals until 48 months post-surgery. Co-morbidity resolution was also assessed across the 48-month observation period. Multivariate regression modelling was used to control analyses for baseline obesity and sociodemographic variables. Results: At 48 months post-surgery mean (±SD) %EBMIL was 60.2 ± 27.6% and 45.4 ± 38.4% for those treated with the 40F and 50F bougie, respectively. After controlling for sociodemographic variables and baseline excess weight, mean %EBMIL was 15.5% greater with a 40F bougie compared with a 50F bougie at the end of follow-up. The likelihood of dyslipidaemia resolution within 48 months post-LSG was 19.0 times greater ( p = 0.006), hypertension resolution 3.6 times greater ( p = 0.005) and type 2 diabetes mellitus resolution 5.2 times greater ( p = 0.034) by 4 years post-surgery in patients treated with the 40F bougie compared with a 50F bougie. Conclusion: Improved obesity reduction and resolution of dyslipidaemia, hypertension and type 2 diabetes mellitus is experienced during the 4 years following surgery by patients treated with a 40F bougie compared with the 50F. These findings remain when controlling for potential confounding clinical and sociodemographic factors.
ACCESSION #
70278548

 

Related Articles

  • Managing Obesity as First-Line Therapy for Diabetes Mellitus. Kelley, David E. // Nutrition in Clinical Care;Jan/Feb98 Supplement 1, Vol. 1 Issue 1, p38 

    Focuses on the management of obesity for the treatment of type 2 diabetes mellitus in the United States. Improvement of weight loss in obese patients; Impact of weight loss on the clinical efficacy of concominant pharmacologic therapy; Reduction of skeletal muscles insulin resistance.

  • Vertical sleeve gastrectomy is not a metabolic procedure. SEELEY, RANDY J.; HARRIS, JASON L.; KAPLAN, LEE M. // Bariatric Times;Apr2014, Vol. 11 Issue 4, pc12 

    The article discusses the mechanism of action of vertical sleeve gastrectomy (VSG). Topics discussed include the effect of VSG to improve plasma triglycerides and glucose regulation, the role of bariatric surgery for the treatment of type 2 diabetes mellitus and obesity and the impacts of VSG on...

  • GIP and Bariatric Surgery. Rao, Raghavendra S.; Kini, Subhash // Obesity Surgery;Feb2011, Vol. 21 Issue 2, p244 

    Bariatric surgery is the most effective modality of achieving weight loss as well as the most effective treatment for type 2 diabetes mellitus (T2DM). Glucose-dependent insulinotropic polypeptide (GIP) is an incretin and is implicated in the pathogenesis of obesity and T2DM. Its role in weight...

  • FXR is a molecular target for the effects of vertical sleeve gastrectomy. Ryan, Karen K.; Tremaroli, Valentina; Clemmensen, Christoffer; Kovatcheva-Datchary, Petia; Myronovych, Andriy; Karns, Rebekah; Wilson-Pérez, Hilary E.; Sandoval, Darleen A.; Kohli, Rohit; Bäckhed, Fredrik; Seeley, Randy J. // Nature;5/8/2014, Vol. 509 Issue 7499, p183 

    Bariatric surgical procedures, such as vertical sleeve gastrectomy (VSG), are at present the most effective therapy for the treatment of obesity, and are associated with considerable improvements in co-morbidities, including type-2 diabetes mellitus. The underlying molecular mechanisms...

  • Diabetes improvement after bariatric surgery is dependent on weight loss. KAPLAN, LEE M.; SEELEY, RANDY J.; HARRIS, JASON L. // Bariatric Times;Apr2014, Vol. 11 Issue 4, pc14 

    The article discusses the role of bariatric surgery for the treatment of type 2 diabetes mellitus (T2DM). Topics discussed include the gastrointestinal weight loss surgical procedures for improvement of T2DM, mechanism of action of postoperative improvement in diabetes and the effects of...

  • Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass (LSG-DJB) for Diabetic Japanese Patients with BMI Less than 35kg/m². YOSUKE SEKI; KENKICHI HASHIMOTO; KAZUNORI KASAMA // Bariatric Times;2015 Supplement A, Vol. 12, pA16 

    The article presents the study which examined the effectiveness of laparoscopic sleeve gastrectomy with duodenojejunal bypass (LSG-DJB) in diabetic patients with less than 35-kilogram per square meter (kg/m2). Also cited are the features of LSG-DJB like the physiological valve called pylorus and...

  • Bariatric surgery not cost saving but "good value.".  // PharmacoEconomics & Outcomes News;10/30/2010, Issue 615, p8 

    The article discusses research on the value of bariatric surgery in treating type 2 diabetes in severely obese patients, which references the study "Cost-effectiveness of Bariatric Surgery for Severely Obese Adults With Diabetes," by T. J. Hoerger, published in the September 2010 issue of...

  • Remission of type 2 diabetes with bariatric surgery.  // Internal Medicine Alert;3/15/2010, Vol. 32 Issue 5, p39 

    The article reports that bariatric surgical procedures can provide remission of type 2 diabetes within days, aside from producing substantial weight loss.

  • It's OK to Disagree. Shikora, Scott // Obesity Surgery;Jun2013, Vol. 23 Issue 6, p735 

    An introduction is presented in which the editor discusses several articles within the issue on topics including bariatric surgery, benefits of metabolic surgery, and treatment of patients with type II diabetes mellitus.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics